⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRFS News
Grifois, S.A.
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
globenewswire.com
GRFS
Grifols Supports AlphaDetect to Accelerate Detection of Alpha-1
prnewswire.com
GRFS
Corporate Conservation Awards Announced at the Tandem Global Conference 2026, Presented by ExxonMobil
accessnewswire.com
FCX
GM
VMC
ASH
GRFS
RRC
BP
WM
CAL
Albuminar-20 (Grifols) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
GRFS
Albuminar-5 (Grifols) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
GRFS
Von Willebrand Disease Treatment Market Size to be Valued at USD 4.70 Billion by 2035 Owing to the Increasing Awareness Globally | SNS Insider
globenewswire.com
CSL
GRFS
Buminate Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
GRFS
Koate-DVI Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
GRFS
Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
globenewswire.com
VNDA
GRFS
BHC
RDHL
MRK
TEVA
PFE
SNY
LLY
ABBV
AZN
CRCT
SPRO
CRNX
Kawasaki Disease Market Analysis and Global Forecast Report 2025-2035 Featuring Prominent Players - Takeda Pharmaceutical, CSL Behring, Grifols, ADMA Biologics, and Octapharma
globenewswire.com
CSL
GRFS
ADMA